GLP-1 Receptor Agonists Show Potential Relative Reduction in CRC Incidence Compared With Aspirin

Default Digital Object Group 2026 Dataset

View at publisher
DOI: 10.1200/adn.25.300412
Cited by: 0

Abstract

A real-world study of more than 250,000 patients with colorectal cancer (CRC) found that GLP-1 receptor agonists are associated with a 26% relative reduction in CRC incidence compared with aspirin (Abstract 18).

Publication details

Journal / source
Default Digital Object Group
Publication date
5 January 2026
Document type
Dataset